Study finds “important shortcomings” in official cancer drug information
Information about drugs is rarely communicated well, particularly to patients Better information is needed to aid treatment decisions Important information about cancer drug benefits, and related uncertainties, is frequently omitted from official prescription drug information sources for clinicians and patients in Europe, finds an analysis published by The BMJ today. Despite the ...

